Ofer Yossepowitch

7.1k total citations · 2 hit papers
164 papers, 5.0k citations indexed

About

Ofer Yossepowitch is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Ofer Yossepowitch has authored 164 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Pulmonary and Respiratory Medicine, 71 papers in Surgery and 39 papers in Urology. Recurrent topics in Ofer Yossepowitch's work include Bladder and Urothelial Cancer Treatments (53 papers), Prostate Cancer Diagnosis and Treatment (50 papers) and Prostate Cancer Treatment and Research (41 papers). Ofer Yossepowitch is often cited by papers focused on Bladder and Urothelial Cancer Treatments (53 papers), Prostate Cancer Diagnosis and Treatment (50 papers) and Prostate Cancer Treatment and Research (41 papers). Ofer Yossepowitch collaborates with scholars based in Israel, United States and Germany. Ofer Yossepowitch's co-authors include James A. Eastham, Scott E. Eggener, Peter T. Scardino, Jack Baniel, Paul Russo, Michael W. Kattan, Fernando J. Bianco, Harry W. Herr, Eric A. Klein and Markus Graefen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ofer Yossepowitch

154 papers receiving 4.9k citations

Hit Papers

Predicting 15-Year Prosta... 2011 2026 2016 2021 2011 2013 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
    2011 468 citations Peter T. Scardino, Ofer Yossepowitch et al. The Journal of Urology profile →
  2. Positive Surgical Margins After Radical Prostatectomy: A Systematic Review and Contemporary Update
    2013 305 citations Ofer Yossepowitch, Alberto Briganti et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ofer Yossepowitch Israel 35 3.4k 1.8k 848 787 740 164 5.0k
Alessandro Larcher Italy 34 2.9k 0.9× 1.5k 0.8× 677 0.8× 901 1.1× 681 0.9× 233 4.1k
Giovanni Lughezzani Italy 45 3.4k 1.0× 2.7k 1.5× 731 0.9× 1.0k 1.3× 1.2k 1.6× 276 5.8k
Marc Zerbib France 34 2.3k 0.7× 2.0k 1.1× 653 0.8× 862 1.1× 880 1.2× 262 4.7k
Vincent P. Laudone United States 33 2.0k 0.6× 1.9k 1.0× 540 0.6× 727 0.9× 835 1.1× 119 4.2k
Gary D. Grossfeld United States 48 3.4k 1.0× 1.9k 1.0× 820 1.0× 1.1k 1.4× 652 0.9× 123 6.0k
Dipen J. Parekh United States 35 1.8k 0.5× 1.7k 0.9× 478 0.6× 662 0.8× 1.0k 1.4× 192 3.9k
Joachim Noldus Germany 35 2.1k 0.6× 1.2k 0.6× 675 0.8× 501 0.6× 655 0.9× 221 3.9k
J. Stephen Jones United States 39 3.3k 1.0× 1.6k 0.9× 1.2k 1.4× 381 0.5× 764 1.0× 155 4.8k
Nicola Fossati Italy 39 3.5k 1.0× 1.4k 0.8× 1.2k 1.4× 385 0.5× 835 1.1× 211 4.7k
Daniel B. Rukstalis United States 34 2.0k 0.6× 1.1k 0.6× 1.0k 1.2× 725 0.9× 1.1k 1.4× 82 3.6k

Countries citing papers authored by Ofer Yossepowitch

Since Specialization
Citations

This map shows the geographic impact of Ofer Yossepowitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofer Yossepowitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofer Yossepowitch more than expected).

Fields of papers citing papers by Ofer Yossepowitch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ofer Yossepowitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofer Yossepowitch. The network helps show where Ofer Yossepowitch may publish in the future.

Co-authorship network of co-authors of Ofer Yossepowitch

This figure shows the co-authorship network connecting the top 25 collaborators of Ofer Yossepowitch. A scholar is included among the top collaborators of Ofer Yossepowitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ofer Yossepowitch. Ofer Yossepowitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Herzberg, Haim, Ziv Savin, Shay Golan, et al.. (2024). Natural history and health care burden of non-curative treatment for muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 42(8). 246.e7–246.e13. 1 indexed citations
3.
4.
Kuten, Jonathan, Ziv Savin, Roy Mano, et al.. (2024). A novel tool to predict lymph node metastasis in patients with prostate cancer based on clinical and 68Ga-PSMA PET/CT parameters. Canadian Urological Association Journal. 19(4). E257–E263. 1 indexed citations
5.
Savin, Ziv, Yaron Ehrlich, Zohar Dotan, et al.. (2024). Transformations in Benign Prostatic Hyperplasia Surgical Practices: A Longitudinal Study of Trends and Predictions. Urologia Internationalis. 109(3). 213–220.
6.
Savin, Ziv, Roy Mano, Barak Rosenzweig, et al.. (2024). Assessing the Impact of Percutaneous Nephrostomy Presence on Neoadjuvant Treatment Quality in Patients With Muscle Invasive Bladder Cancer. Clinical Genitourinary Cancer. 22(2). 491–496.
7.
8.
Cohen, Dan, Charles Levine, David Sarid, et al.. (2023). Staging Prostate Cancer with68Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?. Journal of Nuclear Medicine. 64(7). 1030–1035. 1 indexed citations
9.
Gadoth, Avi, Yifat Alcalay, Idit F. Schwartz, et al.. (2023). Electrolyte Imbalance in Anti-LGI1 Encephalitis. Neurology Neuroimmunology & Neuroinflammation. 10(6). 6 indexed citations
10.
Keizman, Daniel, Moshe Frenkel, Avivit Peer, et al.. (2023). Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study. Nutrients. 15(16). 3533–3533. 6 indexed citations
11.
Yossepowitch, Ofer, et al.. (2023). Complete Blood Count Markers and C-Reactive Protein as Predictors of Testicular Viability in the Event of Testicular Torsion in Adults. Urologia Internationalis. 107(8). 801–806. 3 indexed citations
12.
Savin, Ziv, Ofer Yossepowitch, Jonathan S. Gal, et al.. (2023). 11-item modified frailty index and outcomes after radical cystectomy. Journal of Geriatric Oncology. 14(8). 101627–101627. 3 indexed citations
13.
Kuten, Jonathan, Charles Levine, David Sarid, et al.. (2021). Staging 68 Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement. European Journal of Nuclear Medicine and Molecular Imaging. 49(6). 2077–2085. 13 indexed citations
14.
15.
Savin, Ziv, Gilad Gitstein, Nicola J. Mabjeesh, et al.. (2020). The effect of delaying transperineal fusion biopsy of the prostate for patients with suspicious MRI findings—Implications for the COVID-19 era. Urologic Oncology Seminars and Original Investigations. 39(1). 73.e1–73.e8. 6 indexed citations
16.
Surcel, C., Prasanna Sooriakumaran, Alberto Briganti, et al.. (2014). Preferences in the management of high‐risk prostate cancer among urologists in E urope: results of a web‐based survey. British Journal of Urology. 115(4). 571–579. 22 indexed citations
17.
Mano, Roy, et al.. (2013). Urinary tract infections in patients with orthotopic neobladder. Urologic Oncology Seminars and Original Investigations. 32(1). 50.e9–50.e14. 25 indexed citations
18.
Goldberg, Hanan, Jack Baniel, Roy Mano, et al.. (2013). Low‐dose oral desmopressin for treatment of nocturia and nocturnal enuresis in patients after radical cystectomy and orthotopic urinary diversion. British Journal of Urology. 114(5). 727–732. 8 indexed citations
19.
Jang, Thomas L., Ofer Yossepowitch, Fernando J. Bianco, & Peter T. Scardino. (2007). Low risk prostate cancer in men under age 65: The case for definitive treatment. Urologic Oncology Seminars and Original Investigations. 25(6). 510–514. 20 indexed citations
20.
Lossos, Izidore S., et al.. (1996). [Leukocytoclastic vasculitis associated with naproxen].. PubMed. 130(9). 600–1, 655. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandro Larcher Breakdown of academic impact, for papers by Giovanni Lughezzani Breakdown of academic impact, for papers by Marc Zerbib Breakdown of academic impact, for papers by Vincent P. Laudone Breakdown of academic impact, for papers by Gary D. Grossfeld Breakdown of academic impact, for papers by Dipen J. Parekh Breakdown of academic impact, for papers by Joachim Noldus Breakdown of academic impact, for papers by J. Stephen Jones Breakdown of academic impact, for papers by Nicola Fossati Breakdown of academic impact, for papers by Daniel B. Rukstalis
Rankless by CCL
2026